SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-039960
Filing Date
2023-08-08
Accepted
2023-08-08 17:21:21
Documents
80
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q crbp-20230630.htm   iXBRL 10-Q 2492292
2 EX-31.1 crbp-ex31_1.htm EX-31.1 21041
3 EX-31.2 crbp-ex31_2.htm EX-31.2 21237
4 EX-32.1 crbp-ex32_1.htm EX-32.1 12396
5 EX-32.2 crbp-ex32_2.htm EX-32.2 12255
  Complete submission text file 0000950170-23-039960.txt   10865668

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crbp-20230630.xsd EX-101.SCH 59775
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crbp-20230630_pre.xml EX-101.PRE 430748
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crbp-20230630_def.xml EX-101.DEF 240387
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT crbp-20230630_cal.xml EX-101.CAL 60147
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crbp-20230630_lab.xml EX-101.LAB 517987
74 EXTRACTED XBRL INSTANCE DOCUMENT crbp-20230630_htm.xml XML 2410362
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37348 | Film No.: 231152599
SIC: 2834 Pharmaceutical Preparations